Further work is required for characterization of this pathway in tumor cell biology, essential to advance our knowledge about DSG3 in cancer and the development of potential anti-cancer therapy by manipulating DSG3, such as the usage of specific anti-DSG3 antibodies that spares DSG3 function in cell adhesion. The gene discussed is DSG3; the disease is neoplasm.